• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新西兰利用局部皮质类固醇配药数据得出的儿童湿疹患病率。

Childhood eczema prevalence in New Zealand using topical corticosteroid dispensing data.

机构信息

Women's and Children's Hospital, Adelaide, South Australia, Australia.

Starship Children's Hospital, Te Whatu Ora Auckland, Auckland, New Zealand.

出版信息

Australas J Dermatol. 2024 Nov;65(7):576-584. doi: 10.1111/ajd.14347. Epub 2024 Jul 14.

DOI:10.1111/ajd.14347
PMID:39003644
Abstract

OBJECTIVES

To determine the prevalence of eczema among children in New Zealand.

METHODS

Population-based retrospective observational study utilising national pharmaceutical dispensing records for topical corticosteroids and emollients for all New Zealand children aged 0-14 years from 1st January 2006 to 31st December 2019. Data are reported using descriptive statistics, with comparisons between ethnicities and socioeconomic quintiles undertaken with rate ratios.

RESULTS

Based on dispensing data, the prevalence of eczema for New Zealand children aged 0-14 years in 2018 was 14.0% (95% CI 14.0%-14.1%), with prevalence decreasing in older age groups (children aged <1 year 26.0% (25.6%-26.4%); children aged 10-14 years 8.8% (8.7%-8.9%)). Prevalence was higher in Pacific children (23.6% (23.3%-24.0%)), but slightly lower in Māori children (13.2% (13.0%-13.3%)).

CONCLUSION

Eczema is a common condition affecting a considerable proportion of children in New Zealand. This study provides nationwide paediatric prevalence data for New Zealand, and highlights the increased burden of eczema in Pacific children. Inequity in dispensing of topical corticosteroids is postulated to explain the reduced rates found for Māori children compared to previous studies. These results support the need for further research to determine factors contributing to differing eczema prevalence rates in New Zealand.

摘要

目的

确定新西兰儿童湿疹的患病率。

方法

这是一项利用全国性药物配给记录进行的基于人群的回顾性观察研究,研究对象为 2006 年 1 月 1 日至 2019 年 12 月 31 日期间所有 0-14 岁的新西兰儿童,研究药物包括局部皮质类固醇和保湿剂。数据以描述性统计进行报告,并通过率比比较种族和社会经济五分位数之间的差异。

结果

根据配药数据,2018 年新西兰 0-14 岁儿童的湿疹患病率为 14.0%(95%CI 14.0%-14.1%),且在年龄较大的组中患病率逐渐下降(<1 岁的儿童为 26.0%(25.6%-26.4%);10-14 岁的儿童为 8.8%(8.7%-8.9%))。太平洋岛民儿童的患病率较高(23.6%(23.3%-24.0%)),而毛利儿童的患病率略低(13.2%(13.0%-13.3%))。

结论

湿疹是一种常见疾病,影响了相当一部分新西兰儿童。本研究提供了新西兰全国性的儿科患病率数据,并强调了湿疹在太平洋岛民儿童中负担加重。推测局部皮质类固醇配给的不平等解释了与之前研究相比毛利儿童的比例较低的原因。这些结果支持进一步研究以确定导致新西兰湿疹患病率不同的因素的必要性。

相似文献

1
Childhood eczema prevalence in New Zealand using topical corticosteroid dispensing data.新西兰利用局部皮质类固醇配药数据得出的儿童湿疹患病率。
Australas J Dermatol. 2024 Nov;65(7):576-584. doi: 10.1111/ajd.14347. Epub 2024 Jul 14.
2
Incidence Trends of Atopic Dermatitis in Infancy and Early Childhood in a Nationwide Prescription Registry Study in Norway.在挪威全国处方登记研究中婴儿和幼儿特应性皮炎的发病趋势。
JAMA Netw Open. 2018 Nov 2;1(7):e184145. doi: 10.1001/jamanetworkopen.2018.4145.
3
Appropriateness of prescribing for childhood eczema: evidence from a community-based study.儿童湿疹处方的适宜性:一项基于社区研究的证据
Clin Exp Dermatol. 2006 Sep;31(5):671-3. doi: 10.1111/j.1365-2230.2006.02210.x.
4
Carers' views of topical corticosteroid use in childhood eczema: a qualitative study of online discussion forums.照顾者对儿童湿疹中局部皮质类固醇使用的看法:对在线讨论论坛的定性研究。
Br J Dermatol. 2017 Jun;176(6):1500-1507. doi: 10.1111/bjd.15130. Epub 2017 Feb 3.
5
Topical anti-inflammatory treatments for eczema: network meta-analysis.外用抗炎治疗湿疹:网状荟萃分析。
Cochrane Database Syst Rev. 2024 Aug 6;8(8):CD015064. doi: 10.1002/14651858.CD015064.pub2.
6
Clinical and cost-effectiveness of once-daily versus more frequent use of same potency topical corticosteroids for atopic eczema: a systematic review and economic evaluation.每日一次与更频繁使用相同效力的外用皮质类固醇治疗特应性皮炎的临床疗效和成本效益:一项系统评价和经济评估
Health Technol Assess. 2004 Nov;8(47):iii,iv, 1-120. doi: 10.3310/hta8470.
7
Topical therapy of hand eczema - analysis of the prescription profile from dermatologists in private practice.手部湿疹的局部治疗 - 私人诊所皮肤科医生处方分析。
J Dtsch Dermatol Ges. 2012 Mar;10(3):180-4. doi: 10.1111/j.1610-0387.2011.07787.x. Epub 2011 Sep 17.
8
Pacific people living in New Zealand are most commonly referred with eczema to dermatologists.居住在新西兰的太平洋岛民通常会因湿疹而前往皮肤科医生处就诊。
N Z Med J. 2024 Sep 6;137(1602):150-154. doi: 10.26635/6965.6643.
9
Ethnic differences in acute hospitalisations for otitis media and elective hospitalisations for ventilation tubes in New Zealand children aged 0-14 years.新西兰0至14岁儿童中耳炎急性住院率及通气管择期住院率的种族差异。
N Z Med J. 2015 Jun 12;128(1416):10-20.
10
Adding emollient bath additives to standard eczema management for children with eczema: the BATHE RCT.在湿疹患儿的标准湿疹管理中添加保湿浴添加剂:BATHE RCT。
Health Technol Assess. 2018 Oct;22(57):1-116. doi: 10.3310/hta22570.